NCT05241379View on ClinicalTrials.gov

AURA-2: Augmenting Urinary Reflex Activity

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

April 15, 2024

Study Completion Date

April 15, 2024

Conditions
Overactive BladderUrge Incontinence
Interventions
DEVICE

Amber UI System

The implantable components of the Amber UI system consist of an implantable pulse generator (Picostim Amber IPG), 2 electrode leads with anchoring system

Trial Locations (1)

2650

University Hospital Antwerp, Antwerp

Sponsors
All Listed Sponsors
lead

Amber Therapeutics Ltd

INDUSTRY

NCT05241379 - AURA-2: Augmenting Urinary Reflex Activity | Biotech Hunter | Biotech Hunter